Press Releases

Filter by Category

All Blog Events Podcasts Publications Webinars Workshops

Filter by Program

Filter by Publish Date

May 12, 2025

C-Path’s Translational Therapeutics Accelerator Awards $815,000 Grant for Drug Development Project in Advanced Prostate Cancer

Brisbane-based Queensland Emory Drug Discovery Initiative team awarded funding to advance novel therapy for treatment-resistant pr

May 8, 2025

The year 2025 marks a historic milestone for C-Path as the organization celebrates...

May 6, 2025

TUCSON, Ariz., May 6, 2025 — Critical Path Institute’s® (C-Path) Critical Path for Alpha-1 (CPA-1) consortium is proud to ann

April 23, 2025

TUCSON, Ariz., April 22, 2025  — Critical Path Institute® (C-Path), through its International Neonatal Consortium (INC), jo

March 27, 2025

Serum Glutamate Dehydrogenase Activity Enables Sensitive and Specific Diagnosis of Hepatocellular Injury in Humans TUCSON, Ariz.,

March 27, 2025

New CFO to Lead Financial Strategy and Global Compliance at C-Path TUCSON, Ariz., March 27, 2025 — Critical Path Institute® (C-

March 26, 2025

Collaboration has culminated in meaningful, lasting changes for the benefit of stakeholders...

March 6, 2025

C-Path and Boston Medical Center published results for six biomarkers that could improve the early and accurate detection...

March 6, 2025

C-Path announced the appointments of Steven W. Spector and James A. King to its Board of Directors...

February 18, 2025

Critical Path for Alpha-1 (CPA-1) consortium today announced the addition of biopharmaceutical companies, Kamada and Sanofi.